THE TERRY FOX FOUNDATION in partnership with the Canadian Institutes of Health Research has awarded $27.3 million in new funding to six Canadian research teams to engineer precision medicines for patients whose cancer has relapsed or for whom current treatments are ineffective or non-existent. The Terry Fox Research Institute teams are conducting research into brain,...
To access this subscriber-only content please log in or subscribe.
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe